The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions.

Front Cardiovasc Med · 2026 · PMC13233676 · PMID 42257034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The reduction in LVEDD remained highly significant across all background therapies, including the modern ARNI-based subgroup, which notably demonstrated a complete elimination of within-group heterogeneity ( Supplementary Figure S14 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.